Advertisement
Advertisement
VCEL
Vericel Corporation
30.81
USDSponsored
-0.63
-2.01%
Mar 26, 15:59 UTC -4
Closed
After-Market
30.81
0.00
+0.01%
VCEL Earnings Reports
Positive Surprise Ratio
VCEL beat 23 of 41 last estimates.
56%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$64.91M
/-$0.15
Implied change from Q4 25 (Revenue/ EPS)
-30.14%
/-133.33%
Implied change from Q1 25 (Revenue/ EPS)
+23.41%
/-34.78%
Vericel Corporation earnings per share and revenue
On Feb 26, 2026, VCEL reported earnings of 0.45 USD per share (EPS) for Q4 25, beating the estimate of 0.39 USD, resulting in a 13.12% surprise. Revenue reached 92.92 million, compared to an expected 92.94 million, with a -0.03% difference. The market reacted with a +0.76% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 8 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 64.91 million USD, implying an decrease of -133.33% EPS, and decrease of -30.14% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
MaxCyte, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
FAQ
What were Vericel Corporation's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Vericel Corporation reported EPS of $0.45, beating estimates by 13.12%, and revenue of $92.92M, -0.03% below expectations.
How did the market react to Vericel Corporation's Q4 2025 earnings?
The stock price moved up 0.76%, changed from $37.05 before the earnings release to $37.33 the day after.
When is Vericel Corporation expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Vericel Corporation's next earnings report?
Based on 8
analysts, Vericel Corporation is expected to report EPS of -$0.15 and revenue of $64.91M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement